CDKN2A and cancer: Moreover, the level of CDKN2A gene expression was significantly (p ≤ 0.01, ANOVA/Tukey) decreased in skin cancer cell lines relative to normal skin cell lines, indicating that TES are a good carrier for topical delivery of CXB to the cancer cells, suppressing their progression.